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Abstract
Background: Patellar tendinopathy is a chronic overuse injury of the patellar tendon that is especially prevalent in
people who are involved in jumping activities. Extracorporeal Shockwave Therapy is a relatively new treatment
modality for tendinopathies. It seems to be a safe and promising part of the rehabilitation program for patellar
tendinopathy. Extracorporeal Shockwave Therapy originally used focused shockwaves. Several years ago a new kind
of shockwave therapy was introduced: radial shockwave therapy. Studies that investigate the effectiveness of radial
shockwave therapy as treatment for patellar tendinopathy are scarce. Therefore the aim of this study is to compare
the effectiveness of focussed shockwave therapy and radial shockwave therapy as treatments for patellar
tendinopathy.
Methods/design: The TOPSHOCK study (Tendinopathy Of Patella SHOCKwave) is a two-armed randomised
controlled trial in which the effectiveness of focussed shockwave therapy and radial shockwave therapy are directly
compared. Outcome assessors and patients are blinded as to which treatment is given. Patients undergo three
sessions of either focused shockwave therapy or radial shockwave therapy at 1-week intervals, both in combination
with eccentric decline squat training. Follow-up measurements are scheduled just before treatments 2 and 3, and
1, 4, 7 and 12 weeks after the final treatment. The main outcome measure is the Dutch VISA-P questionnaire,
which asks for pain, function and sports participation in subjects with patellar tendinopathy. Secondary outcome
measures are pain determined with a VAS during ADL, sports and decline squats, rating of subjective improvement
and overall satisfaction with the treatment. Patients will also record their sports activities, pain during and after
these activities, and concurrent medical treatment on a weekly basis in a web-based diary. Results will be analysed
according to the intention-to-treat principle.
Discussion: The TOPSHOCK study is the first randomised controlled trial that directly compares the effectiveness of
focused shockwave therapy and radial shockwave therapy, both in combination with eccentric decline squat
training, for treating patellar tendinopathy.
Trial registration: Trial registration number NTR2774.
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Patellar tendinopathy (PT) is a chronic overuse injury of
the patellar tendon characterised by activity-related
anterior knee pain[1]. Actions that require repetitive
heavy loading of the knee extensor mechanism as seen
in jumping sports like basketball and volleyball are sup-
posed to be the cause, and this is the reason why PT is
often referred to as jumper’s knee [2]. PT is an injury
that can last for years [3]. Several treatment options
have been described in the literature, such as rest, anti-
inflammatory drugs, physical therapy (eccentric exer-
cises), injections and surgical treatments [4].
Another treatment option for patellar tendinopathy is
Extracorporeal Shockwave Therapy (ESWT), a method
that was originally used for lithotripsy (kidney stone
fragmentation). ESWT uses shockwaves to treat the
affected area. A review of the literature concluded that
ESWT seems to be a safe and promising treatment for
PT, although more research is necessary [5]. The study
that showed the most convincing evidence for its effec-
tiveness in treating PT used a combination of ESWT
and eccentric training[6]. It seems therefore important
to combine these two treatment modalities.
Some years ago shockwave generators were introduced
which do not generate focused shockwaves. These gen-
erators have a ballistic source that generates radial
shockwaves. Cleveland et al. (2007) showed that radial
shockwave generators do not generate real shockwaves
and that they act only superficially on the tissue [7].
Nowadays radial shockwave generators are often used
because they are more affordable than focused shock-
wave generators. There is however only one study that
has investigated the effectiveness of radial shockwave
therapy in treating patellar tendinopathy. Lohrer et al.
(2002) demonstrated significant effects on pain and
function, suggesting that radial shockwave therapy is an
effective treatment for patellar tendinopathy [8]. Their
study however was non-randomised and had no control
group, making it difficult to draw firm conclusions
regarding the effectiveness of radial shockwave therapy.
Another study by the group directly compared the effec-
tiveness of radial and focused shockwave therapy for
treating plantar fasciitis,[9] and that study found a small
difference in favour of focused shockwave therapy.
So far no studies have directly compared the effects of
focused shockwave therapy and radial shockwave ther-
apy in patellar tendinopathy in one single randomised
c o n t r o l l e ds t u d y .T h ea i mo ft h eT O P S H O C Ks t u d yi s
therefore to compare the effectiveness on patellar tendi-
nopathy of both therapies in combination with eccentric
decline squat training in a blinded, randomised study.
Methods/Design
Design
The TOPSHOCK study (Tendinopathy Of Patella
SHOCKwave) is a two-armed randomised controlled
trial. The flow chart of the trial is shown in Figure 1.
Patients undergo three sessions of either focused shock-
wave therapy or radial shockwave therapy in combina-
tion with eccentric decline squat training. Outcome
assessors and patients are blinded as to which treatment
is given. Treatment takes place between June 2010 and
November 2011. A baseline measurement will be taken
before treatment session 1. Measurements will also take
place preceding treatment sessions 2 and 3. Sessions are
spaced at 1-week intervals. Follow-up measurements are
taken at 1, 4, 7 and 12 weeks after treatment session 3.
Two weeks after the final treatment session patients
start with a home-based training program consisting of
eccentric decline squat training.
The study was approved by the Medical Ethics Com-
mittee (Number 2009/322) of the University Medical
Center Groningen, The Netherlands. Participants have
to provide informed written consent before
randomisation.
Study population
Patients with PT who visit the Center for Sports Medi-
cine of the University Medical Center Groningen and
are diagnosed with PT by an experienced sports medi-
cine physician, and who meet the inclusion and exclu-
sion criteria, are invited to participate in the study.
Inclusion and exclusion criteria
Patients eligible for inclusion in this study must meet
the following criteria: 1. A history of pain in the patellar
tendon or its patellar or tibial insertion in connection
with training and/or competition; 2. Symptoms for over
three months (to exclude acute inflammatory tendon
problems and de novo partial ruptures); 3. Age between
18 and 50 (to reduce chances of other osteochondrotic
diseases like Sinding-Larsen-Johanson, Osgood-Schlatter
and osteoarthrosis); 4. Palpation tenderness of the patel-
lar tendon; 5. A score below 80 on the VISA-P ques-
tionnaire (see measurements section) [10,11].
E x c l u s i o nc r i t e r i af o rt h es t u d ya r e :1 .A c u t ek n e eo r
patellar tendon injuries; 2. Chronic joint diseases; 3.
Signs or symptoms of other coexisting knee pathology;
4. Contraindications for ESWT (pregnancy, malignancy,
coagulopathy); 5. Knee surgery or injection therapy with
corticosteroids in the last three months; 6. Daily use of
drugs with a putative effect on patellar tendinopathy in
the last year (e.g. non-steroid anti-inflammatory drugs,
fluorchinolones), or use of anticoagulants.
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Blockwise randomisation is performed by an indepen-
dent researcher of another department with a compu-
ter-generated randomisation list. This researcher
informs the physical therapist who administers the
shockwave treatment about the treatment allocation.
Patients’ allocation will be concealed from the patients
and the outcome assessors at all times during the trial.
Patients visiting the UMCG 
Sports Medicine Center and 
who are diagnosed with patellar 
tendinopathy 
Patients who do not 
meet inclusion criteria 
or who meet exclusion 
criteria 
Invitation for participation 
Informed consent 
Randomisation  
Baseline measurement before first 
treatment  
 
3 focused shockwave treatments at 1-
week intervals (with measurement before 
treatments 2 and 3) 
 
Baseline measurement before first 
treatment 
 
3 radial shockwave treatments at 1-week 
intervals (with measurement before 
treatments 2 and 3) 
 
Follow-up at 1, 4, 7 and 12 weeks after last 
treatment 
 
Weekly log of sports activities 
Figure 1 Flowchart of the TOPSHOCK study.
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Both focused and radial shockwave therapy will be given
by one experienced independent physical therapist.
Shockwave therapy is applied with a shockwave device
that has two applicators and can therefore generate both
focused and radial shockwaves (Duolith SD1, Storz
Medical, Tägerwilen, Switzerland). Both shockwave
interventions will be administered without local anaes-
thesia, since several studies have shown that treatment
without anaesthesia is superior to treatment with anaes-
thesia [12-14].
Focused shockwave therapy
Focused shockwave is applied with the focused applica-
tor of the shockwave device. Three sessions will be
administered at one-week intervals. Each session con-
sists of 2000 impulses at 4 Hz. The energy flux density
is 0.12 mJ/mm
2, since this corresponds with 2.4 bar on
the radial shockwave generator of the used machine
(personal communication with manufacturer, 18 May
2010). A fixed energy intensity was chosen instead of a
patient guided energy intensity. A patient guided energy
intensity may influence the results because one type of
s h o c k w a v et h e r a p ym a yb em o r ep a i n f u lc o m p a r e dt o
the other, therefore leading to a difference in energy
intensity level between groups. Rompe et al. (2008) used
2.4 bar for effectively treating insertional Achilles tendi-
nopathy [15], with favourable results and no report of
dropouts because of the treatment being to painful.
Since PT is often also an insertional tendinopathy the
same intensity was chosen in the present study. The
patient will be in supine position with the knee slightly
flexed. Transmission gel is applied between the applica-
tor and the skin. The applicator is slowly moved around
the point of maximal tenderness.
Radial shockwave therapy
The procedure for radial shockwave treatment is the
same as for focused shockwave therapy, the only differ-
ence being that impulses ar ea p p l i e da t8H za n dt h e
treatment intensity is 2.4 bar.
Eccentric decline squat training
Both treatment groups will be given a standard home-
based program for tendon training. Peers (2003) showed
that combining ESWT with eccentric decline squat
training gave positive results [6], therefore this is also
applied in the present study. The home program con-
sists of performing squats on a decline board[16]. Three
sets of 15 repetitions twice a day for 5 days a week will
be prescribed [17]. Performing the exercises takes
approximately 10 minutes per day. The physical thera-
pist will give instructions on the home training program
during the last treatment session. Patients start with the
home program two weeks after the last treatment ses-
sion and continue until the end of the trial (12 weeks
post-treatment). The decline squats should be
performed with mild pain (VAS < 4). If pain decreases,
load will be increased by adding load in a backpack.
Concurrent sports participation and medical treatment
Patients will be allowed to keep on participating in
sports activities. If there is an increase in pain in the
first 48 hours after treatment the participant will be
advised to take paracetamol up to a maximum dose of 3
dd 1000 mg.
Measurements
Baseline measurements
Patients will complete the Dutch VISA-P (Victorian
Institute of Sport Assessment) questionnaire at baseline
[10,11]. The VISA-P questionnaire is designed to mea-
sure severity of patellar tendinopathy. The VISA-P score
is the primary outcome variable. Patients will also com-
plete a baseline questionnaire that asks for demo-
graphics, sports participation and medical history, knee
injuries and previous treatment. Anthropometrics of the
participants are also collected. Pain experienced during
ADL and sports will be rated on a VAS. Finally, pain
during one and during 10 decline squats on a 25°
decline board is rated on a VAS.
Follow-up measurements
At all follow-up moments (before treatments 2 and 3
and 1, 4, 7 and 12 weeks after treatment) the VISA-P
questionnaire is completed. At the 7-week and 12-week
follow-up pain VAS score during ADL, sports and func-
tional tests (decline squat) are also collected. At these
two moments patients answer a question about subjec-
tive improvement and their overall satisfaction with the
treatment. A follow-up of 12 weeks was chosen because
Peers et al. showed favourable effects of a similar proto-
col within a 12-week period [6]. Adverse reactions and
side effects will also be recorded during the follow-up
period.
Web-based diary
Every week the patients will record their sports activ-
ities, pain during and after these activities, and concur-
rent medical treatment in a web-based diary.
Sample size
Sample size is calculated based on the VISA-P score 12
weeks after treatment. A baseline score of 64 points is
expected in symptomatic subjects with an SD of 19
points, based on previous investigations [18]. A differ-
ence in the VISA-P score of 15 points at the end of
the study (12 weeks) is considered to be clinically rele-
vant. With a power of 80% and an alpha of 5%, 28 ten-
dons per group are needed to detect a difference of 15
points between treatments on the VISA-P question-
naire. Since Peers [6] reported no drop-out of patients
because of pain (during or after treatment) in a similar
protocol, we do not expect a higher-than-normal drop-
out rate.
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Results will be analysed using SPSS version 16 (SPSS,
Chicago) according to the intention-to-treat principle.
Descriptive statistics will be used to describe the charac-
teristics of the focused and the radial shockwave group
and the outcome variables at the evaluation moments.
The difference on outcome variables between treatment
groups after 12 weeks will be assessed using t-tests. A
repeated-measures analysis will be used to determine
whether there is a difference on outcome variables
between the two groups over time. Analyses will be per-
formed for the primary and secondary variables. A p-
value < 0.05 is considered statistically significant.
Measurements
Baseline measurements
Patients will complete the Dutch VISA-P (Victorian
Institute of Sport Assessment) questionnaire at baseline
[10,11]. The VISA-P questionnaire is designed to mea-
sure severity of patellar tendinopathy. The VISA-P score
is the primary outcome variable. Patients will also com-
plete a baseline questionnaire that asks for demo-
graphics, sports participation and medical history, knee
injuries and previous treatment. Anthropometrics of the
participants are also collected. Pain experienced during
ADL and sports will be rated on a VAS. Finally, pain
during one and during 10 decline squats on a 25°
decline board is rated on a VAS.
Follow-up measurements
At all follow-up moments (before treatments 2 and 3
and 1, 4, 7 and 12 weeks after treatment) the VISA-P
questionnaire is completed. At the 7-week and 12-week
follow-up pain VAS score during ADL, sports and func-
tional tests (decline squat) are also collected. At these
two moments patients answer a question about subjec-
tive improvement and their overall satisfaction with the
treatment. A follow-up of 12 weeks was chosen because
Peers et al. showed favourable effects of a similar proto-
col within a 12-week period [6]. Adverse reactions and
side effects will also be recorded during the follow-up
period.
Web-based diary
Every week the patients will record their sports activ-
ities, pain during and after these activities, and concur-
rent medical treatment in a web-based diary.
Sample size
Sample size is calculated based on the VISA-P score 12
weeks after treatment. A baseline score of 64 points is
expected in symptomatic subjects with an SD of 19
points, based on previous investigations [18]. A differ-
ence in the VISA-P score of 15 points at the end of the
study (12 weeks) is considered to be clinically relevant.
With a power of 80% and an alpha of 5%, 28 tendons
per group are needed to detect a difference of 15 points
between treatments on the VISA-P questionnaire. Since
Peers [6] reported no drop-out of patients because of
pain (during or after treatment) in a similar protocol,
we do not expect a higher-than-normal drop-out rate.
Statistical analyses
Results will be analysed using SPSS version 16 (SPSS,
Chicago) according to the intention-to-treat principle.
Descriptive statistics will be used to describe the charac-
teristics of the focused and the radial shockwave group
and the outcome variables at the evaluation moments.
The difference on outcome variables between treatment
groups after 12 weeks will be assessed using t-tests. A
repeated-measures analysis will be used to determine
whether there is a difference on outcome variables
between the two groups over time. Analyses will be per-
formed for the primary and secondary variables. A p-
value < 0.05 is considered statistically significant.
Discussion
A number of studies have been conducted on the effect
of shockwave therapy for patellar tendinopathy. A
review of the literature concluded that ESWT seems to
be a safe and promising treatment for PT [5]. All
included studies except one used focused shockwave
therapy.
Radial shockwave generators generate waves that are
very different from those generated by focused shock-
wave generators. Radial shockwaves lack the characteris-
t i cf e a t u r e so fs h o c k w a v e ss u c ha sas h o r tr i s e - t i m e ,a
high peak pressure and non-linearity [7]. Another differ-
ence is that radial shockwaves have a more superficial
effect on tissue, compared to focused shockwaves which
reach a maximal energy in the focus that is located dee-
p e ri n t ot h et i s s u e[ 1 9 ] .S i n c et h ee x a c tw o r k i n g
mechanism of shockwave therapy is not well under-
stood, this difference does not imply that radial shock-
wave therapy is less effective than focused shockwave
therapy [20,21]. Each therapy may even have a different
working mechanism [22].
It is not known whether there is a difference in effec-
tiveness between these therapies as treatment for PT.
Therefore, the aim is of this study is to directly compare
the effects of focused shockwave therapy and radial
shockwave therapy on patellar tendinopathy in a blinded
randomised controlled trial.
Conclusions
The TOPSHOCK study is the first blinded randomised
controlled trial that directly compares focused shock-
wave therapy and radial shockwave therapy in
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Page 5 of 6combination with eccentric decline squat training for
the treatment of patellar tendinopathy.
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